2B4 (CD244, SLAMF4) and CS1 (CD319, SLAMF7) in systemic lupus erythematosus and cancer

Keyphrases

• CD244 100%
• Systemic Lupus Erythematosus 100%
• CD319 100%
• SLAMF7 100%
• Natural Killer Cells 66%
• Basophils 33%
• Cytolytic Activity 33%
• Cancer Disease 33%
• Activation Function 33%
• Monocytes 33%
• T Cells 33%
• Inhibitory Activity 33%
• Hematopoietic Cells 33%
• Inhibitory Receptors 33%
• Activating Receptors 33%
• Signaling Lymphocyte Activation Molecule 33%
• CRACC 33%
• Autoimmune Disease 33%
• Multiple Myeloma 33%
• NK1 Receptor 33%
• Empliciti 33%
• Elotuzumab 33%
• Signaling Adaptors 33%
• X-linked Lymphoproliferative Disease 33%
• CD48 33%
• Immune Regulation 33%
• Chimeric Antigen Receptor T Cells (CAR-T) 33%
• Signaling Domain 33%
• Multiple Myeloma Patients 33%
• CAR-NK Cells 33%

Medicine and Dentistry

• Malignant Neoplasm 100%
• Systemic Lupus Erythematosus 100%
• Natural Killer Cell 100%
• Multiple Myeloma 100%
• Elotuzumab 100%
• Basophil 50%
• Disease 50%
• Receptor 50%
• T Cell 50%
• Signaling Lymphocytic Activation Molecule 50%
• Receptor Family 50%
• Autoimmune Disease 50%
• T Cell Receptor 50%
• Natural Killer Cell Receptor 50%
• Chimeric Antigen Receptor Natural Killer Cell 50%
• Chimeric Antigen Receptor T-Cell 50%
• X-Linked Lymphoproliferative Disease 50%
• Immunoregulation 50%
• Hematopoietic Cell 50%

Immunology and Microbiology

• CD244 100%
• Natural Killer Cell 100%
• Systemic Lupus Erythematosus 100%
• Elotuzumab 66%
• Multiple Myeloma 66%
• Basophil Granulocyte 33%
• T Cell 33%
• T Cell Receptor 33%
• Signaling Lymphocytic Activation Molecule 33%
• Autoimmune Disease 33%
• Hematopoietic Cell 33%
• X-Linked Lymphoproliferative Disease 33%
• CD48 33%
• Immunoregulation 33%
• Chimeric Antigen Receptor T-Cell 33%
• Chimeric Antigen Receptor Natural Killer Cell 33%